In vitro and in vivo behavior of ketoprofen intercalated into layered double hydroxides

Journal of Materials Science: Materials in Medicine

Volumn 21, Issue 11, 2010, Pages 3009-3018

  Silion, Mihaela ^a   Hritcu, Doina ^b   Jaba, Irina M ^c   Tamba, Bogdan ^c   Ionescu, Dunarea ^c   Mungiu, Ostin C ^c   Popa, Ionel Marcel ^b  

^a PETRU PONI INSTITUTE OF MACROMOLECULAR CHEMISTRY   (Romania)

^b GHEORGHE ASACHI TECHNICAL UNIVERSITY OF IASI   (Romania)

^c GRIGORE T POPA UNIVERSITY OF MEDICINE AND PHARMACY   (Romania)

Author keywords

[No Author keywords available]

Indexed keywords

ANTINOCICEPTIVE EFFECT; ELUENT FLOW RATE; FTIR SPECTROSCOPY; IN-VITRO; INORGANIC MATRICES; IONIC EXCHANGE; KETOPROFEN; LAYERED DOUBLE HYDROXIDES; PEPPAS MODEL; RELEASE KINETICS;

FOURIER TRANSFORM INFRARED SPECTROSCOPY; X RAY DIFFRACTION;

ION EXCHANGE;

BIOMATERIAL; KETOPROFEN; LAYERED DOUBLE HYDROXIDE; UNCLASSIFIED DRUG;

ANIMAL EXPERIMENT; ANIMAL MODEL; ANTINOCICEPTION; ARTICLE; CONTROLLED STUDY; DIGESTIVE TRACT PARAMETERS; DRUG FORMULATION; DRUG TOLERABILITY; FLOW RATE; IN VITRO STUDY; IN VIVO STUDY; INFRARED SPECTROSCOPY; INTERCALATION COMPLEX; ION EXCHANGE; KINETICS; MALE; MOUSE; NONHUMAN; PH; PRIORITY JOURNAL; X RAY DIFFRACTION;

ANIMALS; ANTI-INFLAMMATORY AGENTS, NON-STEROIDAL; CHEMISTRY, PHARMACEUTICAL; DRUG CARRIERS; GASTROINTESTINAL TRACT; HYDROXIDES; KETOPROFEN; MALE; MICE; PAIN MEASUREMENT; POLYMERS; SPECTROSCOPY, FOURIER TRANSFORM INFRARED; STOMACH ULCER; TREATMENT OUTCOME; X-RAY DIFFRACTION;

MUS;

EID: 78349244375     PISSN: 09574530     EISSN: None     Source Type: Journal    
DOI: 10.1007/s10856-010-4151-0     Document Type: Article

References (53)

1. CA Heyneman C Lawless-Liday GC Wall 2006 Oral versus topical NSAIDs in rheumatic disease: a comparison Drugs 60 555 574 10.2165/00003495-200060030- 00004
2. RG Marie 1998 Epidemiology of nonsteroidal anti-inflammatory drug-associated gastrointestinal injury Am J Med 104 23S
3. ML Vueba ME Pina F Veiga JJ Sousa LAE Batista de Carvalho 2006 Conformational study of ketoprofen by combined DFT calculations and Raman spectroscopy Int J Pharm 307 56 65 1:CAS:528:DC%2BD2MXht12isr3J 10.1016/j.ijpharm.2005.09.019 16274946 (Pubitemid 41773252)
4. TG Kantor 1986 Ketoprofen: a review of its pharmacologic and clinical properties Pharmacotherapy 6 93 103 1:CAS:528:DyaL28XkvFSmur8%3D 3526298
5. RG Marie 1996 Nonsteroidal anti-inflammatory drugs: practical and theoretical considerations in their selection Am J Med 100 31S 10.1016/S0002-9343(97)89544-7
6. RL Savage PW Moller CL Ballantyne JE Wells 1993 Variation in the risk of peptic ulcer complications with nonsteroidal antiinflammatory drug therapy Arthritis Rheum 36 84 90 1:STN:280:DyaK3s7ktlOqtg%3D%3D 10.1002/art.1780360114 8424842 (Pubitemid 23048683)
7. M Babazadeh 2006 Synthesis and study of controlled release of ibuprofen from the new acrylic type polymers Int J Pharm 316 68 73 1:CAS:528: DC%2BD28XkvVWrt7Y%3D 10.1016/j.ijpharm.2006.02.032 16567069 (Pubitemid 43765692)
8. FP Bonina C Puglia T Barbuzzi PD Caprariis F Palagiano MG Rimoli A Saija 2001 In vitro and in vivo evaluation of polyoxyethylene esters as dermal prodrugs of Ketoprofen, naproxen and diclofenac Eur J Pharm Sci 14 123 134 1:CAS:528:DC%2BD3MXlslGnsb4%3D 10.1016/S0928-0987(01)00163-4 11500258 (Pubitemid 32737534)
9. U Costantino V Ambrogi M Nocchetti L Perioli 2008 Hydrotalcite-like compounds: versatile layered hosts of molecular anions with biological activity Microporous Mesoporous Mater 107 16 149 1:CAS:528:DC%2BD2sXhtlWrt7nE 10.1016/j.micromeso.2007.05.010 (Pubitemid 350102835)
10. M Frunza D Hritcu MI Popa 2009 Intercalation of salicylic acid into ZnAl layered double hydroxides by ion-exchange and coprecipitation method J Optoelectron Adv Mater 11 528 534
11. JA Ko HJ Park SJ Hwang JB Park JS Lee 2002 Preparation and characterization of chitosan microparticles intended for controlled drug delivery Int J Pharm 249 65 74 10.1016/S0378-5173(02)00487-8 (Pubitemid 35333443)
12. Z Liu Y Jiao Y Wang C Zhou Z Zhang 2008 Polysaccharides-based nanoparticles as drug delivery systems Adv Drug Deliv Rev 60 1650 1662 1:CAS:528:DC%2BD1cXhsVSjsL%2FK 10.1016/j.addr.2008.09.001 18848591
13. M del Arco S Gutiérrez C Martín V Rives J Rocha 2004 Synthesis and characterisation of layered double hydroxides (LDH) intercalated with non-steroidal anti-inflamatory (NSAID) drugs J. Solid State Chem 177 3954 3962 1:CAS:528:DC%2BD2cXpslKmu74%3D 10.1016/j.jssc.2004.08.006 2004JSSCh.177.3954D
14. M del Arco E Cebadera S Gutirrez C Martin MJ Montero V Rives J Rocha MA Sevilla 2004 Mg, Al layered double hydroxides with intercalated indomethacin: synthesis, characterisation and pharmacological study J Pharm Sci 93 1649 1658 1:CAS:528:DC%2BD2cXks12hs74%3D 10.1002/jps.20054 15124221 (Pubitemid 38725035)
15. M del Arco A Fernandez C Martin V Rives 2009 Release studies of different NSAIDs encapsulated in Mg, Al, Fe-hydrotalcites Appl Clay Sci 42 538 544 1:CAS:528:DC%2BD1cXhsVelu7fK 10.1016/j.clay.2008.06.014
16. M Frunza MI Popa V Hulea 2007 Controlled release of salicylate from the lamella Zn-Al layered double hydroxide nanocomposite J Optoelectron Adv Mater 9 3376 3378
17. M Frunza G Lisa R Zonda MI Popa 2008 Intercalation of Ketoprofen into Mg-Al hydrotalcites. Synthesis and characterization Rev Chim-Bucharest 59 409 412 1:CAS:528:DC%2BD1cXmtlCqt7w%3D
18. B Li J He DG Evans X Duan 2004 Inorganic layered double hydroxides as a drug delivery systems intercalation and in vitro release of fenbufen Appl Clay Sci 27 199 207 10.1016/j.clay.2004.07.002 (Pubitemid 39483540)
19. M Silion MI Popa G Lisa D Hritcu 2008 New hybrid compounds containing intercalated ciprofloxacin into layered double hydroxides: synthesis and characterization Rev Roum Chim 53 827 831 1:CAS:528:DC%2BD1MXmtlGrsro%3D
20. C del Hoyo 2007 Layered double hydroxides and human health: an overview Appl Clay Sci 36 103 121 10.1016/j.clay.2006.06.010 (Pubitemid 46414156)
21. AS Tarnawski A Ahluwalia V Gandhi X Deng X Xiong 2010 Hydrotalcite protects aging gastric mucosa against NSAID- and ethanol-induced injury by preserving endothelial and progenitor cells. Underlying molecular mechanisms include activation of survivin and VEGF Gastroenterology 138 S-721 10.1016/S0016-5085(10)63316-1
22. BP Yu J Sun MQ Li HS Luo JP Yu 2003 Preventive effect of hydrotalcite on gastric mucosal injury in rats induced by taurocholate World J Gastroenterol 9 1427 1430 1:CAS:528:DC%2BD3sXoslajtrk%3D 12854134
23. S Carlino 1997 The intercalation of carboxylic acids into layered double hydroxides: a critical evaluation and review of the different methods Solid State Ionics 98 73 84 1:CAS:528:DyaK2sXjsFGktbw%3D 10.1016/S0167-2738(96)00619-4
24. Silion M, Popa MI. Preparation and characterization of ketoprofen-layered double hydroxide compounds. J Optoelectron Adv Mater. in press 2010.
25. C Beldie S Dumitriu N Aelenei M Popa MI Popa DumitriuD Bioactive LX Polymers 1989 Kinetics of delayed release neomycin-xanthan complex Biomaterials 10 622 624 1:CAS:528:DyaK3cXosVSjsg%3D%3D 10.1016/0142-9612(89)90117-8 2611312 (Pubitemid 20021119)
26. IM Jaba D Ionescu MI Popa M Silion B Tamba OC Mungiu 2008 The analgesic effect and local tolerance of new anorganic nanohybrid systems with ketoprofen InfoMedica 3 10 13
27. B Tuo G Wen X Wang X Liu H Dong 2010 Estrogen potentiates prostaglandin E2-stimulated duodenal mucosal bicarbonate secretion in mice Gastroenterology 138 S-721 10.1016/S0016-5085(10)63317-3
28. SG Krylova TI Fomina LA Efimova EP Zueva MIu Khotimchenko TG Razina EN Amosova KA Lopatina IuS Khotimchenko 2009 Antiulcer effect of calcium pectate on model of chronic gastric ulcer in rats Eksp Klin Farmakol 72 35 38 1:CAS:528:DC%2BD1MXnt1Sqtr0%3D 19441726
29. SJ Konturek T Brzozowski J Garlicki J Majka J Stachura C Nauert 1991 Intragastric pH in the gastroprotective and ulcer-healing activity of aluminum-containing antacids Digestion 49 140 150 1:CAS:528:DyaK3MXmslSns7c%3D 10.1159/000200713 1769429
30. Carstens E. Quantitative experimental assessment of pain and hyperalgesia in animals and underlying neural mechanisms. In: Carli G, Zimmermann M, editors. Progress in Brain Research, vol 110. Amsterdam: Elsevier Science B.V. 1996. p. 17-31.
31. Derbyshire SWG. Assessing pain in animals. In: Basbaum AI, Kaneko A, Shepherd GM, Westheimer G, Albright TD, Masland RH, Dallos P, Oertel D, Firestein S, Beauchamp GK, Bushnell MC, Kaas JH, Gardner Esther, editors. The senses: a comprehensive reference, vol. 5. Oxford: Elsevier Inc; 2008. p. 969-74.
32. Williams M. Use of animal models for drug discovery. In: Enna SJ, Bylund DB, editors. xPharm: the comprehensive pharmacology reference. New York: Elsevier; 2008. p. 1-7.
33. S Hunskaar K Hole 1987 The formalin test in mice: dissociation between inflammatory and non-inflammatory pain Pain 30 103 114 1:CAS:528: DyaL1cXptQ%3D%3D 10.1016/0304-3959(87)90088-1 3614974 (Pubitemid 17094194)
34. J Olanrewaju BL Newalkar C Mancino S Komrneni 2000 Simplified synthesis of nitrate form of layered double hydroxide Mater Lett 45 307 310 1:CAS:528:DC%2BD3cXmtlOlt7g%3D 10.1016/S0167-577X(00)00123-3
35. ZP Xu HC Zeng 2001 Sulfate-functionized carbon/metal-oxide nanocomposites from hydrotalcite-like compounds Nano Lett 1 703 706 1:CAS:528: DC%2BD3MXotlCjsbc%3D 10.1021/nl010045d 2001NanoL...1..703X (Pubitemid 33672990)
36. 2O as a continuous function of nitrate anions J Phys Chem B 105 1743 1749 1:CAS:528:DC%2BD3MXhtVyns7s%3D 10.1021/jp0029257 (Pubitemid 32255106)
37. M del Arco A Fernández C Martín V Rives 2007 Intercalation of mefenamic and meclofenamic acid anions in hydrotalcite-like matrices Appl Clay Sci 36 133 140 10.1016/j.clay.2006.04.011 (Pubitemid 46414159)
38. F Maestrelli N Zerrouk M Cirri N Mennini P Mura 2008 Microspheres for colonic delivery of ketoprofen-hydroxypropyl-β-cyclodextrin complex Eur J Pharm Sci 34 1 11 1:CAS:528:DC%2BD1cXlslyksbg%3D 10.1016/j.ejps.2008.02.001 18359208
39. F Cavani F Trifiro A Vaccari 1991 Hydrotalcite-type anionic clays: preparation, properties and application Catal Today 11 173 301 1:CAS:528:DyaK38XkslSmtQ%3D%3D 10.1016/0920-5861(91)80068-K
40. S Kanan CS Swamy 1992 Synthesis and physicochemical characterization of cobalt aluminium hydrotalcite J Mater Sci Lett 11 1585 1587 10.1007/BF00740840
41. ZP Xu HC Zeng 1999 Interconversion of brucite-like and hydrotalcite-like phases in cobalt hydroxide compounds Chem Mater 11 67 74 1:CAS:528: DyaK1cXotFajur0%3D 10.1021/cm980420b
42. N Aelenei MI Popa O Novac G Lisa L Balaita 2009 Tannic acid incorporation in chitosan-based microparticles and in vitro controlled release J Mater Sci Mater Med 20 1095 1102 1:CAS:528:DC%2BD1MXjvVentLY%3D 10.1007/s10856-008-3675-z 19160025
43. ® ECD Int J Pharm 318 124 131 1:CAS:528:DC%2BD28XmsVGlsLs%3D 10.1016/j.ijpharm.2006.03. 022 16759827 (Pubitemid 43963305)
44. VS Mastiholimath PM Dandagi SS Jain AP Gadad AR Kulkarni 2007 Time and pH dependent colon specific, pulsatile delivery of theophylline for nocturnal asthma Int J Pharm 28 49 56 10.1016/j.ijpharm.2006.07.045 (Pubitemid 44827555)
45. AP Rokhade NB Shelke SA Patil TM Aminabhavi 2007 Novel interpenetrating polymer microspheres of chitosan and methylcellulose for controlled release of theophylline Carbohydr Polym 69 678 687 1:CAS:528:DC%2BD2sXlvVaksrw%3D 10.1016/j.carbpol.2007.02.008 (Pubitemid 46776848)
46. L Serra J Domenech NA Peppas 2006 Drug transport mechanisms and release kinetics from moleculary designed poly(acrylic acid-g-ethylene glycol) hydrogels Biomaterials 27 5440 5451 1:CAS:528:DC%2BD28Xnt1KkurY%3D 10.1016/j. biomaterials.2006.06.011 16828864 (Pubitemid 44109896)
47. PL Ritger NA Peppas 1987 A simple equation for description of solide release. II. Fickian and anoumalous release from swellable devices J Control Release 5 37 42 1:CAS:528:DyaL2sXkvVeku7s%3D 10.1016/0168-3659(87)90035-6 (Pubitemid 17106644)
48. WF Lee LL Jou 2004 Effect of the intercalation agent content of montmorillonite on the swelling behavior and drug release behavior of nanocomposite hydrogels J Appl Polym Sci 94 74 82 1:CAS:528:DC%2BD2cXnt1Whsr4%3D 10.1002/app.20730 (Pubitemid 39198294)
49. U Costantino M Casciola L Massinelli M Nocchetti R Vivani 1997 Intercalation and grafting of hydrogen phosphates and phosphonates into synthetic hydrotalcites and a.c.-conductivity of the compounds thereby obtained Solid States Ionics 97 203 212 1:CAS:528:DyaK2sXjtl2gsL8%3D 10.1016/S0167- 2738(97)00043-X
50. AC Playle SR Gumming AF Llewellyn 1974 The in vitro antacid and anti pepsin activity of hydrotalcite Pharm Acta Helv 49 298 302 1:CAS:528: DyaE2MXltVehsbw%3D 4618350
51. J Pawlaczyk Z Kokot A Rafinska 1985 In vitro study of the antipeptic activity of antacid preparations Acta Pol Pharm 42 153 158 1:CAS:528: DyaL28XmtFymtg%3D%3D 3936340
52. M Dreyer D Marwinski N Wolf HG Damman 1991 Acid suppression profile of hydrotalcite in man Arzneim-Forsch 41 738 741 1:CAS:528:DyaK3MXltVGrsrk%3D
53. AS Tarnawski M Tomikawa M Ohta IJ Sarfeh 2000 Antacid talcid activates in gastric mucosa genes encoding for EGF and its receptor. The molecular basis for its ulcer healing action J Physiol Paris 94 93 98 1:CAS:528: DC%2BD3cXjtVyhtr0%3D 10.1016/S0928-4257(00)00149-2 10791688 (Pubitemid 30202859)